Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study

Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable short-term safety profile as compared to those reported with mRNA vaccines but adolescent females and those with a history of allergy were at a 1.6 times and three times increased risk of AEFI after taking Covaxin.


http://dlvr.it/T6zdFq

Comments

Popular posts from this blog

40-year-old 1st Indian to win 2 World Masters Powerlifting gold